Prestige Consumer Healthcare falls after downbeat profit forecast
** Shares of health and personal care co Prestige Consumer
Healthcare Inc PBH.N fall 11.4% to $58.64
** Co sees FY23 profit at ~$4.18/shr vs analysts' ests of
~$4.20/shr - Refinitiv
** Forecasts FY 23 rev. at ~$1.12 bln, in line with
analysts' expectations
** PBH posts Q3 revenue of $275.5 mln, beating analysts'
average estimate of $273.7 mln - Refinitiv
** Reports Q3 adj. profit of $1.04/shr, vs ests of $1.01/shr
- Refinitiv
** Stock up 3% in last 12 months
(Reporting by Aditya Samal)
((Aditya.Samal@thomsonreuters.com;))
Recent news on Prestige Consumer Healthcare
See all newsPrestige Consumer Healthcare Inc. reports results for the quarter ended September 30 - Earnings Summary
Prestige Consumer Healthcare Q2 revenue beats on acquisition boost
Prestige Consumer Healthcare Inc reports results for the quarter ended June 30 - Earnings Summary
Prestige Consumer Healthcare beats Q1 revenue estimates, raises 2027 outlook
Brief: Prestige Consumer Healthcare Inc. Announces Offering Of $400 Million Senior Notes